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Introduction
Life on earth has evolved in the presence of a rhythmically
changing environment. There are daily rhythms of light and
dark, seasonal rhythms of daylength, temperature and precipi-
tation, as well as longer-term rhythms of climatic conditions
such as El Niño. The ability of organisms to anticipate the
changes and adjust their physiology to adapt to, survive or
exploit prevailing conditions provides a distinct adaptive advan-
tage to an organism.1,2 As a result, most eukaryotes, and some
prokaryotes, have developed a molecular time-keeping mecha-
nism that can be synchronised with the external environment, to
ensure optimal timing of cellular functions, metabolism and
physiology (for review3–7).
The internal time-keeping mechanism is referred to as the
circadian oscillator or clock. The term ‘circadian’ is derived from
the Latin circa (about) and dies (day). The oscillator generates
rhythms via an autoregulatory transcription-translation feed-
back loop. Although the individual components may not be con-
served across the phyla, the basic mechanism of long-period
rhythm generation is conserved. A feature of circadian rhythms
is that they persist even in conditions of constant darkness or
light, with periods close to 24 h.3–7 However, since the period of
circadian rhythms is not exactly 24 h, the circadian clocks have
the important function of using environmental cues to cause
phase shifts and entrain or synchronise to the external environ-
ment. Light is the most important synchronising agent or
zeitgeber (from the German for ‘time giver ’). Temperature
changes, social cues, meal times and activity also play roles in
setting our internal clock. Integration of the information from
the various zeitgebers ensures synchrony of the internal
physiology with the external 24-h cycle of day and night.8
Many fundamental metabolic, cellular and physiological
processes occur with a circadian rhythm. The cell cycle has a 24-h
rhythm and may be gated in Gap 1 (G1) phase by the circadian
clock.9,10 The 24-h sleep-wake cycle is an obvious function of our
innate rhythmic behaviour. Body temperature displays regular
circadian changes in relation to the sleep-wake schedule and is
the best characterised biological rhythm.8 Certain hormones are
also secreted in an oscillatory manner. For example, melatonin
synthesis and secretion by the pineal gland surges during the
night and is low during the day.11 Cortisol, growth hormone and
testosterone also display daily rhythms of secretion.12–15
Lifestyles in industrialised societies, where artificial light and
activity at night are commonplace, result in mismatches between
external planetary time and internal organismal time. We are
most familiar with this kind of mismatch or desynchronisation in
the phenomenon of jet lag, in which one experiences symptoms
of poor sleep, fatigue, poor appetite and gastrointestinal distur-
bances for some time following extensive transmeridian travel.
This desynchronisation of external and internal time also causes
dysregulation of physiological processes within the body, such
that the subjective time of different organs may be out of phase
with one another. Recent studies suggest a link between circadian
disturbances resulting from night shift work and jet lag, and an
increased risk of cancer. An expert working group for the WHO
International Agency for Research on Cancer (IARC) recently
concluded that shift work that causes circadian rhythm disruption
is ‘probably carcinogenic to humans (Group 2A)’.16 To put this in
context, Group 2A agents as evaluated in the IARC Monographs
on the Evaluation of Carcinogenic Risks to Humans include
acrylamide, chloramphenicol, nitrogen mustard, lead compounds
and diesel engine exhaust fumes.17 It has been shown that the
circadian clock-timing mechanism is vital for cell cycles, DNA
damage responses and tumour suppression.18 Since a persistent
desynchrony could contribute to an increased risk of cancer, this
article reviews the current evidence for this connection and
discusses the disruptions at the molecular level that may lead to
cancer development.
Molecular basis of rhythms
The molecular basis of the circadian clock is the oscillatory
transcription and translation of ‘clock genes’. Current under-
standing of molecular rhythm generation has come from study-
ing model organisms such as cyanobacteria (Synechococcus
elongatus), bread mould (Neurospora crassa), fruit flies (Drosophila
melanogaster), mice (Mus musculus) and thale cress (Arabidopsis
thaliana).3–7,19 The mammalian circadian clock model has been
derived predominantly from studies carried out in mice.
The molecular clockwork of rhythm generation consists of
interlocking positive and negative transcription–translation
feedback loops (Fig. 1). Precise regulation of molecular rhythms
is achieved through post-transcriptional regulation, post-trans-
lational modifications, chromatin remodelling, intracellular
localisation and availability of clock protein partners. The
positive components are two basic helix-loop-helix PER-ARNT-
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Humans have evolved in a rhythmic environment and display daily
(circadian) rhythms in physiology, metabolism and behaviour that are
in synchrony with the solar day. Modern lifestyles have compromised
the exposure to bright light during the day and dark nights, resulting
in the desynchronisation of endogenously generated circadian
rhythms from the external environment and loss of coordination
between rhythms within the body. This has detrimental effects on
physical and mental health, due to the misregulation and uncoupling
of important cellular and physiological processes. Long-term shift
workers who are exposed to bright light at night experience the
greatest disruption of their circadian rhythms. Studies have shown
an association between exposure to light at night, circadian rhythm
disruption and an increased risk of cancer. Previous reviews have
explored the relevance of light and melatonin in cancer, but here we
explore the correlation of circadian rhythm disruption and cancer in
terms of molecular mechanisms affecting circadian gene expression
and melatonin secretion.
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SIM (PAS) domain-containing transcription factors, CLOCK and
BMAL1,19–21 which form heterodimers and bind CACGTG E-box
enhancer elements to activate the transcription of three Period
genes (designated hPer1, hPer2, and hPer3 in humans), two
Cryptochrome genes (hCry1 and hCry2) and the orphan nuclear
receptor Rev-erbα gene.20,22–25 CLOCK is a histone acetyltrans-
ferase, and its activity is stimulated when it is associated with
BMAL1.26 The transcriptional activation of these circadian oscil-
lator genes is achieved through acetylation of histones, but
CLOCK is not required for circadian rhythmicity,27 implying that
an, as yet unidentified, histone acetyltransferase can substitute
for CLOCK. There must also be a histone deacetylase that
functions within the circadian clock, but this has not yet been
identified. PER proteins contain two tandemly arranged PAS
domains, through which they interact with each other and other
proteins.28 PER1 and PER2 are central components of the clock
while PER3 appears to be clock controlled, but not essential for
rhythm generation.29 The PER and CRY proteins negatively
regulate the CLOCK:BMAL1-mediated transcription of their
own genes.9,24,30 PER proteins also act positively to enhance the
transcription of Bmal1, and the greater availability of BMAL1
promotes the heterodimerisation of CLOCK and BMAL1, thus
allowing the cycle to restart.31 REV-ERBα represses Bmal1
transcription through a REV-ERBα/ROR response element in
the Bmal1 promoter.32 The negative and positive loops are
coupled to each other, promoting self-sustained cycling (Fig. 1).
Casein kinase I ε (CKIε) and mitogen-activated protein kinase
(MAPK) have been shown to phosphorylate the PER, CRY,
CLOCK and BMAL1 proteins, regulating their activity, subcellular
organisation and degradation.33–39 The transcriptional activation
activity of BMAL1 is enhanced when phosphorylated by CKIε,36
and the phosphorylated forms of CLOCK and BMAL1 are
predominantly found in the nucleus.37 PER and CRY proteins
must dimerise and be phosphorylated by CKIε prior to nuclear
entry.35, 38 The nuclear localisation signal is thought to be unmasked
when PER is phosphorylated. Phosphorylated PER is recognised
for degradation via the ubiquitin-proteasome pathway.39 Regu-
lated degradation of clock proteins allows the cycle to start
again.4 Physiological control, as well as resetting or entraining
of circadian rhythms, can thus be achieved through inter- and
intracellular signalling.
Where is ‘the clock’ in mammals?
Circadian clocks are found in most of the tissues and cells of
mammals.40,41 There is a hierarchical organisation with a master
clock that orchestrates and synchronises the circadian rhythms
in other tissues. In mammals, the site of the master pacemaker is
in a region of the hypothalamus called the suprachiasmatic
nuclei (SCN).42 The role of this anatomical area was recognised
when circadian rhythms of activity, drinking and feeding were
abolished by electrolytic lesions in the SCN of the rat brain.43 This
master clock responds to external light to reset and synchronise
rhythms with the ambient 24-h cycle. The SCN are located at
an ideal position in the brain to receive visual input via the
retinohypothalamic tract for light entrainment.4 As ocular
photoreception is the only way for humans to gain information
about the light environment, peripheral tissues are synchronised
with the light environment indirectly via signals from the
SCN.44,45 Rhythms of clock gene expression within peripheral
tissues are up to four hours out of phase with the rhythms in the
SCN.40,41 These peripheral clocks are synchronised to the external
light-dark environment via the central clock, but can also be
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Fig. 1. Model of self-sustaining, rhythm-generating, molecular feedback loops in mammals. CLOCK and BMAL1 proteins heterodimerise and bind to E-box promoter
elements to activate transcription of Per1-3, Cry1, Cry2 and Rev-erbα which encode the negative elements of the loop. PER and CRY proteins heterodimerise and
negatively regulate their own transcription and that of Rev-erbα. REV-ERBα represses Bmal1 transcription by binding to a REV-ERBα/ROR response element in its
promoter.The proteins are post-translationally modified by phosphorylation and ubiquitination to alter their stability, sub-cellular localisation or protein-protein interactions.
CKIε: casein kinase Iε; MAPK: mitogen-activated kinase.
entrained by meals, glucocorticoids and activity, independently
of the SCN40,46–48 (Fig. 2).
Entrainment of the central and peripheral clocks
Light, especially blue light, is the dominant zeitgeber for
setting the phase of circadian clocks.49,50 In humans, only the
central clock in the SCN is directly entrained by light received
through ocular light exposure. There is no evidence to support
the suggestion that extraocular light exposure can affect or reset
circadian oscillators in humans.51,52 Rhodopsin and colour opsins
that are required for vision are not required for circadian
photoreception.53 The retinal photoreceptor system for circadian
entrainment requires melanopsin, an opsin-like protein first
identified in the skin of frogs, and possibly other opsin family
pigments in the inner retina.53,54 In 2000, Provencio and cowork-
ers55 showed that melanopsin was present in a group of retinal
ganglion cells. Retinal ganglion cells are the output neurons
from the eye which make up the retinohypothalamic tract (RHT)
which transmits the photic signal to the SCN.55 In response to
light, glutamate is released from the RHT terminal which stimu-
lates receptors in the SCN neurons.56,57 Additionally, the
neurotransmitter γ-aminobutyric acid (GABA) and its receptors
and transporters are present in almost all cells of the SCN,58 and
GABA is implicated in the entrainment of SCN rhythms.
Light input to the SCN can reset the phase of the central circa-
dian pacemaker by inducing Per1 and Per2 gene expression.59–61
Light signals received in the early evening can delay the phase of
the circadian clock, while light signals received late in the night
serve to advance the phase.61 This information is then relayed via
neural and humoral signals to synchronise the clocks of the
peripheral tissues. The humoral signals act as chemical
zeitgebers to cause phase shifts in the peripheral clocks.46 The
pineal hormone melatonin (which peaks during the night) is
imperative to the circadian timing system. The SCN regulates
melatonin synthesis via GABAergic inhibition and glutaminergic
stimulation of the paraventricular nuclei.62 Melatonin receptors
are widely distributed, including in areas of the brain, such as
the SCN, and in peripheral organs and tissues.63,64 The receptors
in the SCN allow melatonin to induce phase shifts in the firing
of neurons.65 The melatonin signal provides information to all
cells, tissues and organs of the body about the time of day,
and increased nocturnal concentrations of melatonin also facili-
tate sleep.66,67 As ocular light rapidly causes a suppression of
melatonin production,68 it is understandable that light at certain
times during the night can cause phase shifts in melatonin
rhythms and affect circadian rhythm signalling.
Humoral signals from the SCN include transforming growth
factor-α and prokineticin 2, which are rhythmically expressed in
the SCN and affect locomotor activity.69 Light is not the only
zeitgeber: meal times can serve as time cues, and plasma glucose
levels that change following meals can affect clock gene expres-
sion in peripheral tissues.48 Glucocorticoids and retinoic acid are
able to cause phase shifts in circadian gene expression in rat-1
fibroblasts and mouse peripheral tissues, even in the absence of
SCN signals.46,70 These internal signals, coupled with the external
light signal, synchronise the central and peripheral circadian
clocks with external time. Working at night not only requires the
presence of light, but also shifts the activity–rest rhythm from
a diurnal habit to a nocturnal one, and can lead to altered
meal times. These factors compound the loss of coordination
between oscillators as they are reset by the different zeitgeber
signals.40,46–48
Circadian disruption: desynchronisation of central and
peripheral clocks
A phase shift in the melatonin rhythm and other circadian
rhythms can be induced by appropriately timed exposure to
light or darkness.49,50 Such alterations occur naturally as day
length changes with the seasons, and are also induced after
transmeridian flights when one rapidly changes time zones, or
during night-time shift work. The effects of rapid changes in
time zones are collectively referred to as jet lag and symptoms
include sleep disruption, poor physical and mental performance
and gastrointestinal disturbances.71 Jet lag recovery involves
shifting the phases of circadian rhythms and re-entraining the
central and peripheral clocks to the new time zone. While the
rhythms of the SCN adjust rapidly to the new time zone,
rhythms in peripheral tissues remain out of synchrony with the
new time zone, and each other, for several cycles.72,73 The signifi-
cance of this delayed re-entrainment is felt by airline pilots, cabin
crew and regular travellers.
Shift work is increasing in the modern, industrialised Western
world, and shift workers experience a ‘social jet lag’ where their
circadian rhythms are out of synchrony with their daily schedule.
Often, night-time shift workers experience continuous bright
light at night, which suppresses natural melatonin production
and causes sleep disturbances and phase shifts in metabolic and
physiological processes.74–77 Circadian dysregulation in night-
time shift workers, due to light exposure at night, can be further
compounded depending on the type of work and their eating
schedules. Even if shift workers are on a permanent night shift,
they very seldom accomplish complete phase adaptation to a
nocturnal activity pattern.72 There are a number of activities that
must take place during the day: childcare and schooling respon-
sibilities, some job-related training or physical examinations,
domestic administrative duties such as banking, and social
events or shopping. This dual pattern of activity can have
profound effects on human health in the long term. Effects on
health include endocrine disorders, psychiatric illnesses, stress-
related disorders, immune responses and carcinogenesis.75,78 The
difference in re-entrainment rates of central and peripheral
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Fig. 2. Entrainment of central and peripheral oscillators in humans. Light signals
are received by the central oscillator in the suprachiasmatic nuclei (SCN) via the
eyes. These are able to directly entrain the central oscillator to environmental
light:dark cycles. Signals from the SCN entrain the rhythms of peripheral
oscillators, thus the phase of peripheral rhythms is slightly delayed relative to those
of the SCN.Other signals such as meal times, activity and temperature can shift the
phase of peripheral rhythms independently of the SCN.
clocks has been proposed as a compounding factor in tumour
development. This is because during the desynchronised
period, when phase adaptation is occurring, tissues are out of
phase with their normal controlling systems, and abnormal
growth and cell proliferation may occur.72,79
Significance of circadian disruption: melatonin and cancer
Melatonin has diverse roles in addition to mediating the
phase-shifting of circadian rhythms.65,80 It is proposed to be
involved in sleep, retinal physiology, reproductive cycles, cancer
development and growth, immune activity, antioxidation and
free radical scavenging, mitochondrial respiration, cardiovascu-
lar function, bone metabolism, intermediary metabolism and
gastrointestinal physiology.66,81–86 Of particular interest, in terms
of rhythm disruption and carcinogenesis, are the functions of
free radical scavenging and enhancement of immune functions.
Studies have shown that melatonin is effective in protecting
against oxidative damage.82–84 Melatonin can thus protect
macromolecules (particularly DNA in terms of carcinogenesis)
from oxidative damage that would otherwise cause detrimental
changes.
Studies in animals have shown the influence of melatonin on
tumour growth. In 1981, Tamarkin and colleagues demonstrated
that removal of the pineal gland in rats enhanced tumour
growth, whilst administration of melatonin reversed or inhib-
ited tumourigenesis.87 A proposed mechanism for the suppres-
sion of tumourigenesis is melatonin’s capacity to suppress the
accumulation of DNA adducts.88 DNA adducts are formed by
carcinogens, which cause mutations and amplification, which in
turn lead to tumour growth. The protective effect could be due
to melatonin’s role in free radical scavenging and the stimulation
of anti-oxidative enzymes. Melatonin also enhances DNA repair,
once damage has been done,89 by increasing the expression of
the tumour-suppressor gene, p53.90 Numerous studies have
shown a wide variety of melatonin’s cancer-suppressive actions,
including the regulation of oestrogen receptor (ERα) expression
and transactivation, calcium/calmodulin activity, protein kinase
C activity, cytoskeletal architecture and function, intracellular
redox status, melatonin receptor-mediated signal transduction
cascades, aromatase and telomerase activities, and fatty acid
transport and metabolism.89,91 A recent study found that blind
women who were unable to perceive light had a lower incidence
of breast cancer than their blind counterparts who were able to
perceive light;92 the authors proposed that light perception and
melatonin production should be investigated in the blind in
terms of the breast cancer-protective effects of the loss of light
perception.92
Significance of circadian disruption: circadian genes,
proteins and cancer
Light-dependent induction of Per1 and Per2 leads to a phase
shift of the central circadian clock.59,60 All of the Per genes are also
rhythmically expressed in peripheral tissues, suggesting that
they have a role outside of the SCN.18 It has been shown that
major biological pathways, such as the cell cycle, DNA damage
response and tumour suppression, are under circadian control.9,18
Clock-controlled genes include key cell-cycle regulators, such as
c-Myc, CyclinD1, Cyclin A and Wee1. Significantly, it has been
shown that there is deregulated expression of these genes in
mutant mice lacking functional PER2.18 These mice displayed
improper cell division and heightened sensitivity to radiation,
suggesting that PER2 functions in regulating the cell cycle and
the DNA damage pathway.
Double-stranded breaks in DNA, caused for example by expo-
sure to UV radiation or ionising irradiation, are detrimental to
the cell and must be repaired prior to cell division. Cells react to
such insults by activating vital replication checkpoints to delay
S-phase progression and G2/M transition so that the DNA can be
repaired; if the damage is irreparable, apoptosis is induced.93,94
Gery et al.95 investigated the importance of PER1 in cell growth
and DNA damage control. They found that PER1 is important in
irradiation-induced apoptosis by elevating c-Myc levels and sup-
pressing the cyclin-dependent kinase inhibitor p21Waf1/Cip1(ref. 95). It
was also shown that PER1 suppresses the growth and trans-
forming potential of cancer cells by regulating key factors in the
cell cycle and DNA damage pathways, which indicates that Per1
could be a tumour-suppression gene. The results showed that
the circadian rhythm functions in peripheral tissues, to control
mitotic events and the cell cycle at multiple stages.95
Down-regulation of Per2 in vivo and in vitro was associated
with an increase in Cyclins D and E and an acceleration of breast
cancer cell and tumour growth.96 Decreased expression of Per1
and Per2 was found in sporadic and familial breast cancers.97 It
was recently demonstrated that misregulation of Per2 or Bmal1
in cancerous tissues was associated with lymph node metastasis
and poor prognosis.98 The same study demonstrated that the
promoters of circadian genes Per1, Per2, Cry1 and Bmal1 were
hypermethylated in breast cancer tissues, leading to misregulation
of gene expression and disruption of circadian rhythms in these
tissues. These results demonstrated that tumourigenesis is asso-
ciated with altered circadian function, whether causal or symp-
tomatic, and suggest that a dysfunctional circadian clock
promotes carcinogenesis.
Correlative studies and implications for lifestyle
recommendations
Recently, a number of epidemiological studies have been
carried out regarding an increased risk of cancer due to lifestyle
habits, such as night-time shift work and light pollution at
night. The majority of the studies have been carried out with
groups of nurses and flight attendants, and consequently most
of the study subjects have been women. Investigations into
the increased risk of breast cancer are therefore predominant,
although there are also studies that show an increased risk of
other cancers such as colorectal, endometrial and prostate
cancer.90,99 The shift status of workers should be examined as a
variable in occupational studies in a broader range of industries
in order to determine whether circadian rhythm disruption
increases the risk of cancers in general. The first published
assessment of shift work and cancer risk showed a 4.3-fold
increased risk of breast cancer in women aged 50 and older, who
had been exposed to more than three years of shift work before
age 30.100 This suggests that the effects of molecular circadian
disruption operate early in the process of carcinogenesis in
breast tissue. Several studies have indicated an increase in the
occurrence of breast cancer in female flight attendants (for
review99). It is unclear whether the combination of shift work
and transmeridian travel has an additive effect on the carcino-
genesis of circadian disruption, thus putting flight crew at a
higher risk than other shift workers. It is also difficult to quantify
the dose of circadian disruption that is carcinogenic. A means to
relate the frequency and duration of shift work to the extent of
circadian disruption, and the magnitude and duration of disrup-
tion that is harmful, must still be established. It will also be useful
to investigate whether there are particular age groups which are
more at risk to the cancer-causing effects of circadian disruption.
There are measures that can be taken to reduce the long-term
effects of shift work. Adaptation of the circadian rhythm to the
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night shift pattern would be beneficial for permanent shift
workers.72 However, this may not be desirable in rapidly rotating
shift workers. If complete adaptation to the night shift is to be
achieved, it has been recommended that workers be exposed to
bright light during the shift, sleep in a darkened room and keep
to a regular sleeping-and-eating cycle.72,101 The proposal for shift
workers to wear dark sunglasses or yellow-tinted glasses that
exclude blue light when travelling home in daylight is only safe
when the shift workers do not drive themselves.102 Generally,
these precautions are not feasible or successful, and perhaps it
would be more reasonable to implement regular cancer screen-
ing in the shift working populations, focusing on early detection
and intervention. Although this may add to the healthcare costs
to companies, preventative steps or early treatment of disease
may prove more cost-effective and beneficial to both the public
and business sectors.
Conclusion
Deregulation of clock gene expression and suppression of
melatonin at night are consequences of a modern lifestyle,
involving both exposure to bright light at night and insufficient
exposure to bright light, akin to natural sunlight, during the day.
It is highly unlikely that humans, or groups of humans, have
adapted biologically to such environmental changes. Recurrent
desynchrony between the environment and central and periph-
eral clocks, as well as a loss of coordination between internal
oscillators, have detrimental health effects in the long term.
These effects have been recognised as potentially carcinogenic
to humans,17 but the observations and suggested mechanisms
need to be confirmed and expanded in well-designed human
studies. Additional studies are also needed to determine the
particular types of shift work and the ‘dose’ of shift work expo-
sure that are damaging.
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